Tag:

OsteoSymbionics

Latest Headlines

OsteoSymbionics gets warned by FDA

December 10, 2010

Craniofacial implant maker OsteoSymbionics has received an FDA warning letter for, among other things, failing maintain procedures to ensure certain design requirements were met. The inspection took

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
HTA in Medtech - Free SymposiumSaturday, June 2, 2012 — ISPOR Washington
Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe

MORE EVENTS

Press Releases

Featured Jobs

Associate Director, Manufacturing Operations Job
Celgene Corporation - Basking Ridge, NJ, US
Research & Development Chemist
C3 Jian - Marina Del Rey, CA
Oncology Knowledge Lead
Merck - Boston, MA
Sr. Director, Statistics Job
Celgene Corporation - Summit, NJ, US
Project Manager, Marketing Excellence Job
Celgene Corporation - Summit, NJ, US

OsteoSymbionics

Latest Headlines

Latest Headlines